Donna A. Sanzari Women's Hospital
One of the only integrated programs focusing on the diagnosis, treatment, and research of early pregnancy loss (under 20 weeks of gestation)
Your Expert Team
This comprehensive program brings together maternal-fetal medicine physicians with specialists from Reproductive Endocrinology and Infertility (REI) at University Reproductive Associates, in nearby Hasbrouck Heights, New Jersey, as well as hematologists from John Theurer Cancer Center (experts in therapy for abnormal blood clotting) and geneticists, pathologists, psychosocial healthcare professionals, and nurses.
What You Can Expect
Patients who have lost a pregnancy between 12 and 20 weeks may be referred to our program through the Division of Maternal-Fetal Medicine or REI. We will begin by taking a thorough medical history and reviewing your prior test results. Please bring your medical records with you to the first visit.
Your doctor will review your previous pregnancy losses and test results, especially those that may indicate if the chromosomes of a lost pregnancy were normal or abnormal. We will run several more tests to assess:
- The anatomy of your uterus, using either an x-ray dye study or hysterosalpingogram (HSG), water ultrasound (hydrosonogram), or hysteroscopy (viewing inside the uterus with a scope)
- Blood clotting (thrombophilia panel)
- Parental chromosomes (genetic testing of you and your partner)
- Ovarian reserve (blood tests and sonogram to see how many eggs you have in your ovaries)
- Ovulation (blood and urine tests and ultrasound)
- Presence of infectious diseases (blood tests)
- The ability of your cervix to maintain a pregnancy (cervical competence or incompetence)
- Presence of diabetes or celiac disease (blood tests)
- The health of your immune system (blood tests)
Treatments for Pregnancy Loss
Your team will look at your test results and let you know if treatment is available to reduce the risk of future pregnancy losses. Examples of these therapies include:
- Minimally invasive surgery
- Medications such as blood thinners
- Use of progesterone or fertility drugs
Clinical trials of investigational therapies may be available for patients with normal test results. Your doctor will let you know if you are eligible for a clinical trial.
Staff in the MFM and REI Divisions are equipped to fully support the emotional demands of women suffering from recurrent early pregnancy loss. All pregnancies are monitored very closely from as early as a pregnancy is detected. Colleagues in the Hematology Division of the John Theurer Cancer Center (experts in therapy for abnormal blood clotting) partner with the Center for Early Pregnancy Loss team to ensure seamless coordination of care. Working together, the model of collaborative care brought to life in the Hackensack-Meridian Health System Center for Early Pregnancy Loss allows the best possible outcomes anywhere.